0005 000504 23 Apr 2004 | Other | ¥0.02 Per Share |
0005 000504 14 Jun 1993 | Other | ¥0.02 Per Share |
23 May 2025 Date | | - Cons. EPS | - EPS |
24 May 2024 Date | | - Cons. EPS | - EPS |
24 Apr 2024 Date | | - Cons. EPS | - EPS |
0005 000504 23 Apr 2004 | Other | ¥0.02 Per Share |
0005 000504 14 Jun 1993 | Other | ¥0.02 Per Share |
23 May 2025 Date | | - Cons. EPS | - EPS |
24 May 2024 Date | | - Cons. EPS | - EPS |
24 Apr 2024 Date | | - Cons. EPS | - EPS |
Biotechnology Industry | Healthcare Sector | Mr. Changqiao You CEO | XSHE Exchange | CNE000000263 ISIN |
CN Country | 378 Employees | - Last Dividend | 15 Jan 2007 Last Split | 28 Oct 1991 IPO Date |
Landfar Bio-medicine Co., Ltd has positioned itself as a key player in the field of biomedical technology since its inception in 1991. Based in Changsha, China, the company specializes in a broad array of services and products that span across two main segments: Biomedicine, and Energy Saving and Environmental Protection. These segments reflect the company's dual focus on advancing healthcare through biomedical innovations, as well as contributing to environmental conservation and energy efficiency. With its deep-rooted commitment to research and development in stem cell therapy and environmental management, Landfar Bio-medicine Co., Ltd continues to expand its reach and impact in both the medical and environmental sectors.